On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

Just a heads up, if you buy something through our links, we may get a small share of the sale. It’s one of the ways we keep the lights on here. Click here for more. A federal jury in California ruled ...

A U.S. jury ruled on November 15, 2025, that Apple must pay Masimo $634 million in a patent infringement case over smartwatch technology, awarding Masimo a major victory after years of litigation.

A federal jury in California has determined that Apple must pay medical device company Masimo $634 million in damages for infringing a patent related to blood oxygen monitoring technology. Reuters ...

The W1 medical watch [Image courtesy of Masimo] Masimo (Nasdaq: MASI) + today scored a significant legal victory over Apple in the latest installment of the long-running legal battle between the two ...

The latest legal slugfest between local medical device maker Masimo Corp. and its nemesis, Apple Inc., began last week in a Santa Ana federal courtroom. In a civil trial before a jury of eight, Masimo ...

Masimo has beat its Q3 revenue estimates by $4.5 million, as several financial analysts double down on the company’s “buy” rating. The company reported third quarter revenues of $371.2M, up 7.6% ...

Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...